Lnk Governs chemokine-directed trafficking of CD8+ T cells in melanoma

Yael Derdikman Ofir(Technion – Israel Institute of Technology), Igal Louria‐Hayon(Rambam Health Care Campus), Miran Aswad(Rambam Health Care Campus), Yasmine Khier(Rambam Health Care Campus), Michal Hayun(Rambam Health Care Campus), Ghazal Kheshaiboun(Rambam Health Care Campus), Narmeen Ghanayiem(Rambam Health Care Campus), Yaniv Zohar(Technion – Israel Institute of Technology), Antonina Pechkovsky(Rambam Health Care Campus), Yishai Ofran(Shaare Zedek Medical Center)
Molecular Therapy Oncology
July 1, 2026
10.1016/j.omton.2026.201288
Cited by 0

Related Papers

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
|New England Journal of Medicine|2020|432
CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis
|Journal of Clinical Investigation|2014|178
The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission
|Blood|2019|97
E6AP promotes the degradation of the PML tumor suppressor
|Cell Death and Differentiation|2009|93